---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-004696"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2022-02-15T23:59:59+00:00"
generated_at: "2026-06-27T08:01:17.071425+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# PAVmed appoints Joan B. Harvey to board; grants 179,350 stock options

## Summary
- Appointed Joan B. Harvey as Class C director effective Feb 11, 2022; will serve on audit and compensation committees.
- Granted ten-year option to purchase 179,350 shares of common stock at $2.05 per share, vesting in 12 quarterly installments starting Mar 31, 2022.
- Harvey is president of Care Solutions for Evernorth (Cigna's health services business) with over 20 years of healthcare leadership.
- No transactions with Harvey requiring disclosure under Item 404(a) of Regulation S-K were reported.

## SEC filing metadata
- accession: 0001493152-22-004696
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2022-02-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315222004696/0001493152-22-004696-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315222004696/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-004696
- JSON: https://secwatch.observer/filing/0001493152-22-004696.json
- Plain text: https://secwatch.observer/filing/0001493152-22-004696.txt

## Key facts
- Executive change
  Joan B. Harvey was appointed as Class C director at PAVmed Inc..
  - Action: appointed
  - Role: Class C director
  source text: Effective February 11, 2022, the board of directors of PAVmed Inc. (the “ Company ”) appointed Joan B. Harvey as a Class C director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1624326/000149315222004696/0001493152-22-004696-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.